Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

A woman who watched her husband die from pancreatic cancer is calling for improved investment in research into the disease.

Thousands of families feel the heartbreaking consequences of this lack of action every year. Unlike other cancers where ...

Once a year, they shut down roads across the city, giving 30,000+ cyclists free rein in a 40-mile journey through all five ...

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

Brenda Johnson, a beloved wife, mother and grandmother of Southill tragically passed away from pancreatic cancer in April last year, just ...

Amplia Therapeutics and Immutep have released clinical trial results that promise more effective treatments for pancreatic and lung cancers ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, will present new data from Cohort 1 of the GOBLET study at the 2025 ...